The landscape of dementia diagnosis has advanced drastically with the arrival of subtle biomarkers, which includes amyloid PET scans, tau imaging, and blood-based exams that could detect Alzheimer's pathology yrs right before signs and symptoms emerge. Although these technological improvements depict extraordinary development in being familiar with